Cardiology
Eplontersen Effects on Myocardial Remodeling in Transthyretin Amyloid Cardiomyopathy: Insights from the CARDIO-TTRansform CMR Study
Eplontersen significantly reduces myocardial amyloid burden and improves cardiac structure and function in ATTR-CM, as demonstrated by serial cardiovascular magnetic resonance imaging over 140 weeks.
